--- 
title: Acute kidney injury 
layout: default 
redirect_from: "/projects/acutekidneyinjury/"
permalink: /acutekidneyinjury 
--- 

# Acute kidney injury

## The regulatory network of systemic and renal hemodynamics

### Description

<p><a href="https://trecard.com/akiprev-project/" target="_blank">AKIPREV</a> aims at developing a computerized clinical decision support system (CDSS) that will help physicians to stratify patients, and optimize antihypertensive and analgesic drug treatments. AKIPREV-CDSS works on a conceptually innovative approach that evaluates the individual’s functional phenotype, based on a multiparametric computation of selected analytical parameters and personal data. Objectives of this project are:</p>

<ol>
<li>To develop and preclinically validate a disease and pharmacological model of interactions among the key regulatory mechanisms and molecular players of systemic and renal hemodynamics, and the associated markers (descriptors) that describe the status of the hemodynamic network, on which drugs exert their effects.</li>
<li>To develop a computerized mathematical model (algorithm) that, when fed with the values of the descriptors of each individual patient will:
  
<ul>
<li>Describe the status of their hemodynamic network; and based on it,</li>
<li>Predict the effect of drugs and drug combinations on blood pressure, and renal function.</li>
</ul>

<li>To carry out clinical validation and adjustment of the computerized model with data from patients subject to drug treatments.</li>
</ol>

<p>The project will:</p>

<ol>
<li>Provide personalized treatment for hypertension and pain based on disease mechanisms knowledge.</li>
<li>Integrate patient’s multidimensional and longitudinal data.</li>
<li>Use proteomics and pharmacogenomics, systems biomedicine, network analysis and computational modelling.</li>
<li>Perform pre-clinical and clinical studies.</li>
<li>Address sex and gender differences.</li>
<li>Involve patient associations</li>
<li>Consider regulatory aspects.</li>
<li>Develop a dissemination and commercialisation plan.</li>
<li>Focus on a complex disease, hypertension, with high prevalence and economic impact.</li>
</ol>

<h3 id="developersteam">Development Team</h3>

<table>
<tr>
<td style="width: 100px;"><img src="../images/team/FranciscoLopezHernandez.jpg" alt="Francisco J. López-Hernández" /></td>
<td><strong>Francisco J. López-Hernández, PhD</strong><br /><strong>Salamanca Biomedical Research Institute & University of Salamanca, Spain</strong><br />Group Leader, Senior Researcher and Assistant Professor</td>
</tr>
<tr>
<td><img src="../images/team/CarlosMartinezSalgado.jpg" alt="Carlos Martínez-Salgado" /></td>
<td><strong>Carlos Martínez-Salgado, PhD</strong><br /><strong>Salamanca Biomedical Research Institute & University of Salamanca, Spain</strong><br />Head of Research Group, Senior Research Scientist and Associate Professor</td>
</tr>
<tr>
<td><img src="../images/team/AnaMoralesMartin.jpg" alt="Ana I. Morales Martín" /></td>
<td><strong>Ana I. Morales Martín, PhD</strong><br /><strong>University of Salamanca & Salamanca Biomedical Research Institute, Spain</strong><br />Head Professor</td>
</tr>
<tr>
<td><img src="../images/team/AnitaTLayton.jpg" alt="Anita T. Layton" /></td>
<td><strong>Anita T. Layton, PhD</strong><br /><strong>Duke University, Durham, North Carolina, USA</strong><br />
Professor of Mathematics, Medicine & Biomedical Engineering at the Duke University, Durham, North Carolina, USA<br />
Professor of Applied Mathematics at the University of Waterloo, Waterloo, Canada</td>
</tr>
<tr>
<td><img src="../images/team/BertrandDeMeulder.jpg" alt="Bertrand De Meulder" /></td>
<td><strong>Bertrand De Meulder, PhD</strong><br /><strong>European Institute for Systems Biology and Medicine, France</strong><br />Researcher</td>
</tr>
</table>

<h3 id="editorscommittee">Editorial Panel (Domain Experts)</h3>

<table>
<tr>
<td style="width: 100px;"><img src="../images/team/ArminKurtz.jpg" alt="Armin Kurtz" /></td>
<td><strong>Armin Kurtz, MD</strong><br /><strong>Universität Regensburg, Germany</strong><br />Chair of Physiology, Institut für Physiologie</td>
</tr>
<tr>
<td><img src="../images/team/JoseMartinGuerrero.jpg" alt="José D. Martín Guerrero" /></td>
<td><strong>José D. Martín Guerrero, PhD</strong><br /><strong>University of Valencia, Spain</strong><br />Associate Professor, Intelligent Data Analysis Laboratory</td>
</tr>
<tr>
<td><img src="../images/team/JolantaMalyszko.jpg" alt="Jolanta Malyszko" /></td>
<td><strong>Jolanta Malyszko, MD, PhD</strong><br /><strong>Medical University of Bialystok, Poland</strong><br />Professor, 2nd Department of Nephrology and Hypertension</td>
</tr>
<tr>
<td><img src="../images/team/AlbertoOrtiz.jpg" alt="Alberto Ortiz" /></td>
<td><strong>Alberto Ortiz, MD, PhD</strong><br /><strong>Fundacion Jimenez Diaz & University Autonoma of Madrid, Spain</strong><br />Chief of Nephrology, Professor of Medicine</td>
</tr>
<tr>
<td><img src="../images/team/PatrickCDHaese.jpg" alt="Patrick C. D'Haese " /></td>
<td><strong>Patrick C. D'Haese, PhD</strong><br /><strong>University of Antwerp, Belgium</strong><br />Head Laboratory of Pathophysiology, Department Biomedical Sciences</td>
</tr>
<tr>
<td><img src="../images/team/RhianMTouyz.jpg" alt="Rhian M Touyz" /></td>
<td><strong>Rhian M. Touyz, MBBCh, PhD, FRCP, FRSE</strong><br /><strong>University of Glasgow, UK</strong><br />Director of Research Institute, Institute of Cardiovascular and Medical Sciences<br />British Heart Foundation Chair of Cardiovascular Medicine</td>
</tr>
</table>
